Evaluation of Shoulder Strength and Deltoid Stiffness After Reverse Shoulder Arthroplasty (RSA)
Launched by ŞENSU DINÇER · Jan 15, 2024
Trial Information
Current as of July 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how strong the shoulder joint is and how elastic (or flexible) the deltoid muscle is in patients who have had a reverse shoulder arthroplasty, which is a type of shoulder surgery. Researchers want to find out if there are differences in strength and elasticity between the shoulder that had surgery and the healthy shoulder. They also aim to see if there is a link between how well patients can use their shoulder and the strength and elasticity of the operated shoulder.
To be eligible for this study, participants should have had the reverse shoulder surgery due to a specific shoulder problem and should have been followed for at least a year after the surgery. It’s important that their other shoulder is healthy. Participants will take part in strength tests and specific ultrasound measurements, and they will also fill out some questionnaires about their shoulder function. This study is currently not recruiting participants, but it’s an important step in understanding recovery after this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having undergone reverse shoulder arthroplasty surgery due to arthropathy because of unilateral rotator cuff tear
- • Followed for at least 12 months after surgery.
- • The other unoperated shoulder is healthy.
- Exclusion Criteria:
- • Patients with revision reverse shoulder arthroplasty
- • Having inflammatory diseases
- • Not having adequate range of motion to be able to perform isokinetic test
About şensu Dinçer
Şensu Dinçer is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and a strong adherence to regulatory standards, Şensu Dinçer collaborates with leading researchers and healthcare institutions to design, implement, and oversee clinical trials. The organization emphasizes rigorous methodologies and ethical practices, ensuring the highest levels of integrity and transparency in all its studies. Through its comprehensive approach, Şensu Dinçer aims to contribute significantly to the development of safe and effective treatments across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported